ProQR Therapeutics (PRQR) Free Cash Flow Growth (1y) (2014 - 2022)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 60.84% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 88.70% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -15.72% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 66.37% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.98% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 137.65% |
| 10 | ProQR Therapeutics | 174.11 Mn | 66.54 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -445.04% |
| Sep 30, 2022 | -63.99% |
| Jun 30, 2022 | -30.43% |
| Mar 31, 2022 | -60.43% |
| Dec 31, 2021 | 133.06% |
| Sep 30, 2021 | 16.64% |
| Jun 30, 2021 | -7.01% |
| Mar 31, 2021 | -86,441.12% |
| Dec 31, 2020 | -6.99% |
| Sep 30, 2020 | -14.65% |
| Jun 30, 2020 | 7.87% |
| Mar 31, 2020 | 99.88% |
| Dec 31, 2019 | -125,095.58% |
| Sep 30, 2019 | -101.09% |
| Jun 30, 2019 | -93.83% |
| Mar 31, 2019 | -196,720,898.60% |
| Dec 31, 2018 | -201.07% |
| Sep 30, 2018 | -39,605,085.20% |
| Jun 30, 2018 | 41.92% |
| Mar 31, 2018 | -99.92% |
| Dec 31, 2017 | 100.03% |
| Sep 30, 2017 | 99.89% |
| Dec 31, 2016 | -41.84% |
| Sep 30, 2016 | -67.64% |
| Dec 31, 2015 | -400.98% |
| Sep 30, 2015 | 99.87% |
| Mar 31, 2015 | -121.73% |
| Dec 31, 2014 | -291.31% |
| Sep 30, 2014 | -555.91% |